Images
Participants
Contact
The research on the relationship between fat and metastasis performed by Salvador Aznar Benitah and Gloria Pascual at IRB Barcelona figures among the eight studies competing in the 7th "La Vanguardia de la Ciencia" Prize—an award that seeks to give greater visibility to research of excellence. Until 28 February, readers will be able to vote for the study they consider most important.
The newspaper explains that "A strategy against metastasis" is a study that may be relevant for both the prevention and treatment of cancer. Salvador Aznar-Benitah and Gloria Pascual have identified a protein that appears to be crucial for the development and growth of metastases. The translation of this protein to clinical practice is currently being studied. The study was published in the journal Nature in December 2016.
If you want to vote, click on the following link: Los lectores eligen la mejor ciencia del año (Spanish)
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
